Category: Cancer Treatment
Oceania Cancer Treatment
-
2025 Asia-Pacific Cancer Biomarkers Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on equipment or ... Read More
-
2024-2029 Australia Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers, Market Barriers and Risks
... Pipeline, Emerging Opportunities for Suppliers, Market Barriers and Risks This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The ... Read More
-
Brachytherapy Market Research Report Information, By Product (Afterloaders & Applicators, Radioactive Seeds, Electronic Brachytherapy, Imaging Systems, and Others), By Type (High Dose-Rate (HDR) Brachytherapy, Low Dose-Rate (LDR) Brachytherapy), By Technique (Interstitial Brachytherapy, Intracavitary Brachytherapy), By Indication (Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, and Others), By End-Users (Hospitals & Specialty Clinics, Cancer Treatment Centers, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Industry Forecast Till 2032
... Indication (Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, and Others), By End-Users (Hospitals & Specialty Clinics, Cancer Treatment Centers, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Industry ... Read More
-
2024-2029 New Zealand Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Tests - Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Assays - High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline
... High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging ... Read More
-
CAR T-Cell Therapy Market by Target Antigens (CD19, BCMA, CD20, CD19/22, and Other Target Antigens), Target Indication (Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Large B-cell Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, and Others), Key Geographies (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World), Sales Forecast of Drugs and Leading Players: Industry Trends and Global Forecasts, Till 2035
... Others), Key Geographies (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World), Sales Forecast of Drugs and Leading Players: Industry Trends and Global Forecasts, Till 2035 CAR T-CELL ... Read More
-
Chemotherapy Market, By Drugs (Alkylating agents, Antimetabolites, Anti-tumor Antibiotics, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Liver Cancer, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Chemotherapy is a type of cancer treatment that uses one or ... Read More
-
Metastatic Lung Adenocarcinoma Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, and Others), End User (Hospitals, Specialty Clinics, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034
... Latin America, and Middle East & Africa) – Market Forecast, 2025–2034 The global metastatic lung adenocarcinoma treatment market size is expected to reach USD 14.17 billion by 2034, according to a new study by Polaris ... Read More
-
2024 Asia-Pacific Cancer Immunotherapy Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 Asia-Pacific Cancer Monocolonal Antibodies Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Asia-Pacific Immunotherapy Drugs Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Asia-Pacific Lung Cancer Surgery Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Asia-Pacific Pd-1 And Pd-L1 Inhibitors Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 Asia-Pacific Breast Cancer Therapeutics Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Asia-Pacific Cancer Diagnostics Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Asia-Pacific Cancer Supportive Care Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and Other Payloads), Target Antigens (HER-2 (ERBB2), CD79b, Trop-2, BCMA (TNFRSF17 / BCM), CD19, CD22, Tissue Factor, CD30, CEACAM5, Nectin 4 and Others) And Key Geographical Regions (North America (US, Canada), Europe (Germany, UK, France, Italy, Spain), and Asia-Pacific (China, Australia, Japan)): Industry Trends and Global Forecasts, Till 2035
... Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and ... Read More
-
Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy), Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... and Rest of the World) Industry Forecast till 2032 In 2023, the e-Visa market was estimated to be worth USD 933.4 million. With a compound annual growth rate (CAGR) of 11.1% from 2024 to 2032, ... Read More
-
Clinical Decision Support System Market Research Report Information by Component (Software, Services, and Hardware) By Product (Integrated CDSS and Standalone CDSS), By Model (Knowledge-Based CDSS and Non-Knowledge-Based CDSS), By Delivery Mode (On-Premise CDSS and Cloud-Based CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced Clinical Decision Support Systems and Conventional Clinical Decision Support Systems), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Industry Forecast till 2032
... CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced ... Read More
-
Biologics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Monooclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectius Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) According to our new research study ... Read More
-
Nuclear Medicine Market Research Report Information by Type (Diagnosis [SPECT Radiopharmaceuticals {Tc99m, I-123, and Others} and PET Radiopharmaceuticals {F18, C11 Choline, and Others}] and Therapeutic (Alpha Emitters [Actinium-225 (Ac-225), Radium-223 (Ra-223), and Others], Beta Emitters [Yttrium-90 (Y-90), Lutetium-177 (Lu-177), and Others], and Brachytherapy Isotopes [Iodine-125 (I-125) and Others]), by Application (Neurology, Cardiology, Oncology [Prostate Cancer, Breast Cancer, Lung and Bronchus Cancer, Thyroid Cancer, Colorectal Cancer, and Others], and Others), by End User (Hospitals & Diagnostic Centers, Research Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2032
... [Yttrium-90 (Y-90), Lutetium-177 (Lu-177), and Others], and Brachytherapy Isotopes [Iodine-125 (I-125) and Others]), by Application (Neurology, Cardiology, Oncology [Prostate Cancer, Breast Cancer, Lung and Bronchus Cancer, Thyroid Cancer, Colorectal Cancer, and Others], and Others), by ... Read More
-
Chronic Pain Market, By Drug Class (Opioids, Non-steroidal anti-inflammatory drugs (NSAIDS), Anticonvulsants, Antidepressants, and Others), By Indication (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer pain, Migraine, Fibromyalgia, and Others), By Application (Musculoskeletal, Neuropathy, Oncology, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Chronic pain is defined as any pain lasting for more ... Read More
-
Global Cancer Therapeutics And Biotherapeutics Market, By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Giloblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others), By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Hormone Therapy, Biotherapy, and Others), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, and Research & Development), By End User (Hospitals & Clinics, Cancer Care Centers, Research Institutes, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Targeted Therapy, Immunotherapy, Radiation Therapy, Hormone Therapy, Biotherapy, and Others), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, and Research & Development), By End User (Hospitals & Clinics, Cancer Care Centers, Research ... Read More
-
2024 What's Next for Australia Diagnostics Market? - Supplier Shares and Strategies, 2023-2028 Volume and Sales Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2023 supplier shares, strategies, as well as 2023-2028 volume and sales forecasts for 500 ... Read More
-
2024 What's Next for New Zealand Diagnostics Market? - Supplier Shares and Strategies, 2023-2028 Volume and Sales Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2023 supplier shares, strategies, as well as 2023-2028 volume and sales forecasts for ... Read More
-
2024 New Zealand Nucleic Acid Testing (NAT) Market Opportunities - Competitive Shares and Growth Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests - Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks
... Pipeline, Market Barriers and Risks This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. ... Read More
Research Assistance
